ConductScience.org, home

Paper33558705

USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription.

Jie X and 11 others. Cell Death Differ, 2021. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription. Papers, record 33558705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33558705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription.
PubMed
Journal
Cell Death Differ
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
4.41
iCite
Revised in PubMed
2022-04-17
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jie XXiaohua
2Fong WPWilliam Pat
3Zhou RRui
4Zhao YYe
5Zhao YYingchao
6Meng RRui
7Zhang SSheng
8Dong XXiaorong
9Zhang TTao
10Yang KKunyu
11Wu GGanghttps://orcid.org/0000-0001-6558-3508
12Xu SShuangbinghttps://orcid.org/0000-0002-9166-7788

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Jumonji Domain-Containing Histone DemethylasesMajor topic
Lung NeoplasmsMajor topic
Radiation ToleranceMajor topic
Transforming Growth Factor beta2Major topic
Ubiquitin ThiolesteraseMajor topic
UbiquitinationMajor topic
Animals
Carcinogenesis
Cell Line, Tumor
Cell Transformation, Neoplastic
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
Signal Transduction
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81874041National Natural Science Foundation of China (National Science Foundation of China)PubMed
81874218National Natural Science Foundation of China (National Science Foundation of China)PubMed
2019CFA063Natural Science Foundation of Hubei Province (Hubei Provincial Natural Science Foundation)PubMed

Source PubMed

Download CSV of grants

References2

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110987278Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines.Cancer Res2000https://conductscience.org/library/papers/10987278PubMed
231285948Stabilization of PTGES by deubiquitinase USP9X promotes metastatic features of lung cancer via PGE2 signaling.Am J Cancer Res2019https://conductscience.org/library/papers/31285948PubMed

Download CSV of references

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
42852008Geno-guided targeting of ferroptosis: a multi-layered network to overcome radioresistance in lung cancer.Front Cell Dev Biol2026https://conductscience.org/library/papers/42852008PubMed
42794600Peripheral Blood Transcriptomic Profile Associated with Cutaneous Radiation Injury in Cancer Patients Undergoing Radiotherapy.Int J Mol Sci2026https://conductscience.org/library/papers/42794600PubMed
42724680Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances.Am J Cancer Res2026https://conductscience.org/library/papers/42724680PubMed
42582931Epigenetics in lung cancer precision medicine: from bench to bedside-a narrative review.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42582931PubMed
42343427Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42343427PubMed
42315669USP9X regulates copper-induced CASP9/CASP3/GSDME-dependent pyroptosis by deubiquitinating JAK1.Apoptosis2026https://conductscience.org/library/papers/42315669PubMed
41946992Global analysis of cancer cell responses to USP9X inhibition.EMBO J2026https://conductscience.org/library/papers/41946992PubMed
41885448PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators.J Enzyme Inhib Med Chem2026https://conductscience.org/library/papers/41885448PubMed
41661469Mechanism of FOXP2 in the Hepatocellular Carcinoma Progression via Ferroptosis Through RBM15B-Mediated m6A Modification.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/41661469PubMed
41635813Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets.PeerJ2026https://conductscience.org/library/papers/41635813PubMed
41614901Role of the Super-Enhancer Component Bromodomain Protein 4 in the Radiation Response of Human Head and Neck Squamous Cell Carcinoma Cells.Curr Issues Mol Biol2026https://conductscience.org/library/papers/41614901PubMed
41522168Bibliometrics and potential gene analysis of post-translational modifications in lung cancer.J Thorac Dis2025https://conductscience.org/library/papers/41522168PubMed
41490602The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma.Cancer Res Commun2026https://conductscience.org/library/papers/41490602PubMed
41488674PSMD14 drives lung adenocarcinoma progression through HMMR stabilization and dual activation of TGF-β/Smad and PI3K/AKT/mTOR signaling.Front Immunol2025https://conductscience.org/library/papers/41488674PubMed
41477347How histone modifications influence cellular radiosensitivity: Pharmaceutically targeting epigenetic regulators as a promising avenue to overcome radioresistance.Acta Pharm Sin B2025https://conductscience.org/library/papers/41477347PubMed
41301681Molecular Mechanisms of the Ubiquitin-Specific Proteases (USPs) Family in Biliary Tract Cancer and Targeted Intervention Strategies.Biomedicines2025https://conductscience.org/library/papers/41301681PubMed
41039553Decoding the ubiquitin network: molecular mechanisms and therapeutic vulnerabilities for precision radio-sensitization in cancer.Mol Cancer2025https://conductscience.org/library/papers/41039553PubMed
40675967Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40675967PubMed
40580997Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors.Oncologist2025https://conductscience.org/library/papers/40580997PubMed
40427072Targeting the ZMYM2-ANXA9 Axis with FLT3 Inhibitor G749 Overcomes Oxaliplatin Resistance in Colorectal Cancer.Biomedicines2025https://conductscience.org/library/papers/40427072PubMed

See all 61 cited byDownload CSV of cited by

Genes36

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
ATP2C127032PubTator's text mininghttps://conductscience.org/library/genes/27032NCBI Gene
BMP2650PubTator's text mininghttps://conductscience.org/library/genes/650NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CCNE1898PubTator's text mininghttps://conductscience.org/library/genes/898NCBI Gene
CHEK211200PubTator's text mininghttps://conductscience.org/library/genes/11200NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
EEF21938PubTator's text mininghttps://conductscience.org/library/genes/1938NCBI Gene
FBXO2226263PubTator's text mininghttps://conductscience.org/library/genes/26263NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
GDF1110220PubTator's text mininghttps://conductscience.org/library/genes/10220NCBI Gene
IL3RA3563PubTator's text mininghttps://conductscience.org/library/genes/3563NCBI Gene
IRS48471PubTator's text mininghttps://conductscience.org/library/genes/8471NCBI Gene
JUND3727PubTator's text mininghttps://conductscience.org/library/genes/3727NCBI Gene
KDM4A9682PubTator's text mininghttps://conductscience.org/library/genes/9682NCBI Gene
KDM4B23030PubTator's text mininghttps://conductscience.org/library/genes/23030NCBI Gene
KDM4C23081PubTator's text mininghttps://conductscience.org/library/genes/23081NCBI Gene
MBD28932PubTator's text mininghttps://conductscience.org/library/genes/8932NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
PPP2R2A5520PubTator's text mininghttps://conductscience.org/library/genes/5520NCBI Gene

See all 36 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33558705

GET https://conductscience.org/api/papers/v1/33558705/cited_by?page=2